KLWA
RGEN icon

Kelly Lawrence W & Associates’s Repligen RGEN Stock Holding History

Kelly Lawrence W & Associates’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.08M Buy
59,250
+4,780
+9% +$587K 1.73% 20
2026
Q1 		$6.42M Buy
54,470
+13,370
+33% +$1.87M 1.78% 22
2025
Q4 		$6.73M Hold
41,100
– – 1.64% 23
2025
Q3 		$5.49M Buy
+41,100
New +$4.99M 1.33% 23

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Kelly Lawrence W & Associates's RGEN Position: Q2 2026 in Review

Kelly Lawrence W & Associates increased its Repligen (RGEN) stake by 8.8% in Q2 2026, buying an estimated $587K and bringing the position to 59,250 shares worth $8.08M. The position accounts for 1.73% of the portfolio, ranked #20.

Kelly Lawrence W & Associates first reported a position in RGEN in Q3 2025 and has held it in 4 quarters since. 477 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Kelly Lawrence W & Associates held 59,250 shares of Repligen worth $8.08M as of Q2 2026.
  • Kelly Lawrence W & Associates bought 4,780 Repligen shares in Q2 2026, an estimated $587K.
  • Repligen made up 1.73% of Kelly Lawrence W & Associates's portfolio in Q2 2026, its #20 holding.
  • Kelly Lawrence W & Associates first reported a position in Repligen in Q3 2025 and has held it in 4 quarters since.
  • 477 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Kelly Lawrence W & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.